Pomanda estimates the enterprise value of NEVRO MEDICAL LIMITED at £19.2m based on a Turnover of £18.6m and 1.03x industry multiple (adjusted for size and gross margin).
nevro medical limitedEstimated Valuation
£3.6m
Pomanda estimates the enterprise value of NEVRO MEDICAL LIMITED at £3.6m based on an EBITDA of £481k and a 7.54x industry multiple (adjusted for size and gross margin).
nevro medical limitedEstimated Valuation
£31.1m
Pomanda estimates the enterprise value of NEVRO MEDICAL LIMITED at £31.1m based on Net Assets of £14.6m and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nevro Medical LimitedOverview
Nevro Medical Limited is a live company located in cheltenham, GL50 3PR with a Companies House number of 07268550. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in May 2010, it's largest shareholder is
nevro corp.
with a 100% stake. Nevro Medical Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£18.6m with
declining
growth in recent years.
Pomanda's financial health check has awarded Nevro Medical Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 6 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
6 Strong
0 Regular
6 Weak
Size
annual sales of £18.6m, make it larger than the average company (£4.8m)
£18.6m - Nevro Medical Limited
£4.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -13%, show it is growing at a slower rate (6.6%)
-13% - Nevro Medical Limited
6.6% - Industry AVG
Production
with a gross margin of 59.6%, this company has a lower cost of product (38.3%)
59.6% - Nevro Medical Limited
38.3% - Industry AVG
Profitability
an operating margin of 2.5% make it less profitable than the average company (5.7%)
2.5% - Nevro Medical Limited
5.7% - Industry AVG
Employees
with 53 employees, this is above the industry average (27)
53 - Nevro Medical Limited
27 - Industry AVG
Pay Structure
on an average salary of £128.9k, the company has a higher pay structure (£54k)
£128.9k - Nevro Medical Limited
£54k - Industry AVG
Efficiency
resulting in sales per employee of £351.8k, this is more efficient (£171.4k)
£351.8k - Nevro Medical Limited
£171.4k - Industry AVG
Debtor Days
it gets paid by customers after 51 days, this is later than average (42 days)
51 days - Nevro Medical Limited
42 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (32 days)
0 days - Nevro Medical Limited
32 days - Industry AVG
Stock Days
it holds stock equivalent to 42 days, this is more than average (33 days)
42 days - Nevro Medical Limited
33 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 92 weeks, this is more cash available to meet short term requirements (22 weeks)
92 weeks - Nevro Medical Limited
22 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 8.5%, this is a lower level of debt than the average (62.5%)
8.5% - Nevro Medical Limited
62.5% - Industry AVG
NEVRO MEDICAL LIMITED financials
EXPORT
Nevro Medical Limited's latest turnover from December 2023 is £18.6 million and the company has net assets of £14.6 million. According to their latest financial statements, Nevro Medical Limited has 53 employees and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Nov 2010
Turnover
18,643,196
18,864,253
17,285,253
27,870,237
22,140,726
20,528,534
16,941,472
14,997,703
17,084,891
9,619,471
22,343,723
1,320,461
567,803
Other Income Or Grants
Cost Of Sales
7,530,680
8,181,654
8,270,866
14,318,906
9,467,699
9,762,601
7,090,476
7,689,508
8,605,359
3,879,269
14,565,254
845,998
355,691
Gross Profit
11,112,516
10,682,599
9,014,387
13,551,331
12,673,027
10,765,933
9,850,996
7,308,195
8,479,532
5,740,202
7,778,469
474,463
212,112
Admin Expenses
10,649,109
9,918,103
8,782,332
12,328,457
11,350,792
9,346,178
8,665,697
5,849,237
7,343,032
5,257,595
7,420,238
342,730
135,954
Operating Profit
463,407
764,496
232,055
1,222,874
1,322,235
1,419,755
1,185,299
1,458,958
1,136,500
482,607
358,231
131,733
76,158
Interest Payable
7,055
3,104
397
Interest Receivable
4,507
836
358
Pre-Tax Profit
456,352
764,496
228,951
1,222,874
1,321,838
1,419,755
1,185,299
1,458,958
1,136,500
482,607
362,738
132,568
76,516
Tax
-265,260
-191,209
-147,373
-310,920
-240,715
-322,397
-123,177
242,966
20,971
-70,171
-83,430
-31,816
-19,894
Profit After Tax
191,092
573,287
81,578
911,954
1,081,123
1,097,358
1,062,122
1,701,924
1,157,471
412,436
279,308
100,752
56,622
Dividends Paid
Retained Profit
191,092
573,287
81,578
911,954
1,081,123
1,097,358
1,062,122
1,701,924
1,157,471
412,436
279,308
100,752
56,622
Employee Costs
6,831,367
6,705,205
6,281,194
9,629,938
7,894,620
6,153,680
5,810,193
4,657,242
5,408,840
2,968,530
6,209,244
360,549
158,366
Number Of Employees
53
55
54
87
58
139
49
36
26
36
151
9
4
EBITDA*
480,967
824,168
310,957
1,335,519
1,344,688
1,419,755
1,185,299
1,458,958
1,136,500
482,607
358,231
131,733
76,158
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Nov 2010
Tangible Assets
3,224
20,784
80,456
192,165
143,253
Intangible Assets
Investments & Other
31,899
31,899
31,899
31,899
31,899
31,899
18,289
Debtors (Due After 1 year)
Total Fixed Assets
35,123
52,683
112,355
192,165
175,152
31,899
31,899
18,289
Stock & work in progress
886,275
876,394
1,132,741
2,497,998
1,429,025
1,777,480
1,914,377
1,661,896
2,038,343
1,221,813
1,250,417
Trade Debtors
2,652,453
3,742,386
2,636,718
4,348,639
4,993,497
4,850,724
3,611,654
3,358,685
3,046,874
8,817,284
2,085,269
159,715
45,322
Group Debtors
9,258,280
4,468,413
6,262,828
1,433,507
2,350,794
2,433,576
2,313,246
1,985,042
646,198
Misc Debtors
714,294
154,210
109,048
68,662
104,193
90,582
242,637
407,494
413,043
Cash
2,408,533
6,520,517
3,498,758
11,227,110
4,050,495
1,906,583
1,217,802
1,122,806
2,745,938
1,990,641
1,611,703
190,990
143,232
misc current assets
total current assets
15,919,835
15,761,920
13,640,093
19,575,916
12,928,004
11,058,945
9,299,716
8,535,923
8,890,396
12,029,738
4,947,389
350,705
188,554
total assets
15,954,958
15,814,603
13,752,448
19,768,081
13,103,156
11,090,844
9,331,615
8,554,212
8,890,396
12,029,738
4,947,389
350,705
188,554
Bank overdraft
Bank loan
Trade Creditors
6,021
84,935
136,891
422,834
71,143
56,836
46,181
52,807
105,983
68,551
4,509,707
192,331
130,932
Group/Directors Accounts
64,791
139,529
234,432
2,089,942
321,488
1,049,882
1,358,949
2,886,883
4,571,697
9,831,226
other short term finances
hp & lease commitments
other current liabilities
1,280,903
2,157,128
1,429,447
2,440,020
2,710,508
2,142,301
2,068,174
1,362,086
1,925,348
1,279,844
total current liabilities
1,351,715
2,381,592
1,800,770
4,952,796
3,103,139
3,249,019
3,473,304
4,301,776
6,603,028
11,179,621
4,509,707
192,331
130,932
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
2,321
21,796
26,701
2,828
total long term liabilities
2,321
21,796
26,701
2,828
total liabilities
1,351,715
2,383,913
1,800,770
4,974,592
3,129,840
3,251,847
3,473,304
4,301,776
6,603,028
11,179,621
4,509,707
192,331
130,932
net assets
14,603,243
13,430,690
11,951,678
14,793,489
9,973,316
7,838,997
5,858,311
4,252,436
2,287,368
850,117
437,682
158,374
57,622
total shareholders funds
14,603,243
13,430,690
11,951,678
14,793,489
9,973,316
7,838,997
5,858,311
4,252,436
2,287,368
850,117
437,682
158,374
57,622
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Nov 2010
Operating Activities
Operating Profit
463,407
764,496
232,055
1,222,874
1,322,235
1,419,755
1,185,299
1,458,958
1,136,500
482,607
358,231
131,733
76,158
Depreciation
17,560
59,672
78,902
112,645
22,453
Amortisation
Tax
-265,260
-191,209
-147,373
-310,920
-240,715
-322,397
-123,177
242,966
20,971
-70,171
-83,430
-31,816
-19,894
Stock
9,881
-256,347
-1,365,257
1,068,973
-348,455
-136,897
252,481
-376,447
816,530
-28,604
1,250,417
Debtors
4,260,018
-643,585
3,157,786
-1,597,676
73,602
1,207,345
416,316
1,645,106
-4,711,169
6,732,015
1,925,554
114,393
45,322
Creditors
-78,914
-51,956
-285,943
351,691
14,307
10,655
-6,626
-53,176
37,432
-4,441,156
4,317,376
61,399
130,932
Accruals and Deferred Income
-876,225
727,681
-1,010,573
-270,488
568,207
74,127
706,088
-563,262
645,504
1,279,844
Deferred Taxes & Provisions
-2,321
2,321
-21,796
-4,905
23,873
2,828
Cash flow from operations
-5,011,652
2,210,937
-2,947,257
1,629,600
1,985,213
114,520
1,092,787
-183,173
5,735,046
-9,452,287
1,416,206
46,923
141,874
Investing Activities
capital expenditure
32,807
-161,557
-165,706
Change in Investments
31,899
-31,899
13,610
18,289
cash flow from investments
908
-129,658
-165,706
-13,610
-18,289
Financing Activities
Bank loans
Group/Directors Accounts
-74,738
-94,903
-1,855,510
1,768,454
-728,394
-309,067
-1,527,934
-1,684,814
-5,259,529
9,831,226
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
981,461
905,725
-2,923,389
3,908,219
1,053,196
883,328
543,753
263,144
279,780
-1
1,000
interest
-7,055
-3,104
-397
4,507
836
358
cash flow from financing
899,668
810,822
-4,782,003
5,676,673
324,405
574,261
-984,181
-1,421,670
-4,979,749
9,831,225
4,507
836
1,358
cash and cash equivalents
cash
-4,111,984
3,021,759
-7,728,352
7,176,615
2,143,912
688,781
94,996
-1,623,132
755,297
378,938
1,420,713
47,758
143,232
overdraft
change in cash
-4,111,984
3,021,759
-7,728,352
7,176,615
2,143,912
688,781
94,996
-1,623,132
755,297
378,938
1,420,713
47,758
143,232
nevro medical limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for nevro medical limited. Get real-time insights into nevro medical limited's credit score, group structure and payment trends.
Perform a competitor analysis for nevro medical limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other mid companies, companies in GL50 area or any other competitors across 12 key performance metrics.
nevro medical limited Ownership
NEVRO MEDICAL LIMITED group structure
Nevro Medical Limited has no subsidiary companies.
Ultimate parent company
NEVRO CORP
#0079467
1 parent
NEVRO MEDICAL LIMITED
07268550
NEVRO MEDICAL LIMITED Shareholders
The sole shareholder of Nevro Medical Limited is Nevro Corp..
nevro corp.
100%
nevro medical limited directors
Nevro Medical Limited currently has 3 directors.
The longest serving directors include
Mr Kashif Rashid (Sep 2018) and
Mr Roderick MacLeod (Jun 2020).
82990 - Other business support service activities n.e.c.
incorporation date
May 2010
age
15
incorporated
UK
ultimate parent company
NEVRO CORP
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
BYRD & LINK AUDIT & ACCOUNTANCY SERVICES LIMITED
address
fourth floor st james house, st james' square, cheltenham, GL50 3PR
Bank
HSBC BANK PLC
Legal Advisor
-
nevro medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to nevro medical limited. Currently there are 0 open charges and 1 have been satisfied in the past.
nevro medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NEVRO MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
nevro medical limitedCompanies House Filings - See Documents
